These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25772061)

  • 41. Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.
    Park JY; Lee SY; Kim HR; Seo MD; Chung KY
    Arch Pharm Res; 2016 Mar; 39(3):293-301. PubMed ID: 26825061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. G-protein-coupled receptor structure, ligand binding and activation as studied by solid-state NMR spectroscopy.
    Ding X; Zhao X; Watts A
    Biochem J; 2013 Mar; 450(3):443-57. PubMed ID: 23445222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
    Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
    Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural biology of G protein-coupled receptor signaling complexes.
    Edward Zhou X; Melcher K; Eric Xu H
    Protein Sci; 2019 Mar; 28(3):487-501. PubMed ID: 30311978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. G protein-coupled receptors: from ligand identification to drug targets. 14-16 October 2002, San Diego, CA, USA.
    Chantry D
    Expert Opin Emerg Drugs; 2003 May; 8(1):273-6. PubMed ID: 14610927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ubiquitination of G protein-coupled receptors: functional implications and drug discovery.
    Dores MR; Trejo J
    Mol Pharmacol; 2012 Oct; 82(4):563-70. PubMed ID: 22700696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural studies of G protein-coupled receptors.
    Lu M; Wu B
    IUBMB Life; 2016 Nov; 68(11):894-903. PubMed ID: 27766738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GPCR Allosteric Modulator Discovery.
    Wu Y; Tong J; Ding K; Zhou Q; Zhao S
    Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A closer look into G protein coupled receptor activation: X-ray crystallography and long-scale molecular dynamics simulations.
    Vanni S; Rothlisberger U
    Curr Med Chem; 2012; 19(8):1135-45. PubMed ID: 22300050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Catecholamine receptors: prototypes for GPCR-based drug discovery.
    Emery AC
    Adv Pharmacol; 2013; 68():335-56. PubMed ID: 24054152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
    Sriram K; Insel PA
    Mol Pharmacol; 2018 Apr; 93(4):251-258. PubMed ID: 29298813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in G protein-coupled receptor allostery: from function to structure.
    Christopoulos A
    Mol Pharmacol; 2014 Nov; 86(5):463-78. PubMed ID: 25061106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challenges.
    Ayoub MA; Crépieux P; Koglin M; Parmentier M; Pin JP; Poupon A; Reiter E; Smit M; Steyaert J; Watier H; Wilkinson T
    MAbs; 2017 Jul; 9(5):735-741. PubMed ID: 28475474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. G protein-coupled receptors: novel targets for drug discovery in cancer.
    Lappano R; Maggiolini M
    Nat Rev Drug Discov; 2011 Jan; 10(1):47-60. PubMed ID: 21193867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biasing GPCR signaling from inside.
    Shukla AK
    Sci Signal; 2014 Jan; 7(310):pe3. PubMed ID: 24473194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GPCR drug discovery-moving beyond the orthosteric to the allosteric domain.
    Felder CC
    Adv Pharmacol; 2019; 86():1-20. PubMed ID: 31378249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biased agonism: An emerging paradigm in GPCR drug discovery.
    Rankovic Z; Brust TF; Bohn LM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):241-250. PubMed ID: 26707396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The year in G protein-coupled receptor research.
    Millar RP; Newton CL
    Mol Endocrinol; 2010 Jan; 24(1):261-74. PubMed ID: 20019124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.